The news summaries appearing in SNMMI SmartBrief are based on original information from multiple
internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher.
The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may
be directed to SmartBrief at snmmi@smartbrief.com.

Top Story

PET, MRI shed light on brain variations in young men with autismA study published in the Archives of General Psychiatry that used PET to measure microglial activation in the brains of young men with autism spectrum disorder found the patients' brains showed significantly higher binding potential values in the cerebellum, midbrain and other areas. Another study published in the same journal that used MRI to measure brain cortical volume found that young men with the disorder had significantly higher cortical thickness within the frontal lobe regions. The findings indicate that young men with ASD have variations in brain surface anatomy and more brain immune activation. PhysiciansBriefing.com/HealthDay News
(11/29)

Study offers clues on schizophrenia's molecular mechanismResearchers using PET imaging have discovered that patients with schizophrenia who were not responding to antipsychotic treatment have fairly normal levels of dopamine synthesis capacity. The finding may help shed light on why dopamine-blocking antipsychotic drugs do not work in this patient group, according to a study published in the American Journal of Psychiatry. Researchers said more studies are needed to understand whether presynaptic dopamine synthesis capacity was normal in treatment-resistant patients when their condition began and whether it predates exposure to antipsychotics. MedicalXpress.com/News release
(11/29)

The Truth about Cloud Security72% of businesses are using the cloud. 56% said they are still figuring out exactly where they can use the cloud more. Why would so many businesses already trust these services with their own and their clients' most sensitive data? While security risks are real, the cloud is also more secure than you think. Read this eBook to learn more

Embrace Disruptive InnovationTraditional business is constantly being impacted by overwhelming and sudden shifts in the marketplace. This new normal is "disruptive innovation". Read this white paper to learn what disruptive innovation is and how your company can use cloud ERP to stay in the game. Download the white paper >

ADVERTISEMENT

News from the Field

Survey: Some patients do not know radiologists are doctorsFindings from a survey presented at a radiology meeting showed that only 53.5% of respondents realize radiologists are physicians. The survey also showed 27.7% of respondents think radiologists are not doctors, while 18.8% did not give a guess. Around 80% of those surveyed said they wanted to know who interpret the results of their scans, while 83% said they want access to radiologists' reports. "Radiologists are patients' physicians," said Dr. Peter Miller of the Indiana University School of Medicine. "We must further explore the barriers in our medical system that prevent radiologists from being visible to patients." AuntMinnie.com (free registration)
(11/29)

CMS rolls out $692M in EHR incentives in Oct.CMS paid $692 million in EHR incentives to hospitals, doctors and other eligible professionals in October, bringing the total payout to slightly more than $8.4 billion since the program commenced. The agency has paid $2.84 billion in Medicare and Medicaid incentives for physicians and other professionals since early last year, while hospitals received almost $5.38 billion during the same period, CMS said. Modern Healthcare (subscription required)
(11/29)

From SNMMI

Upcoming webinar: "Phases of Drug Development" — Dec. 6 at 3 p.m. ESTJoin Eileen Smith, MBA, CNMT, for an informative discussion on the phases of drug development. Investigational drugs, including imaging biomarkers, must navigate through specific phases before they can be cleared for approval by the FDA for clinical use. You'll hear how and why these phases were developed, what each phase entails and their overall impact on drug development. Register today!